在资源有限的国家,以药房为基础的疫苗接种的质量和安全要求有限
Kidanemariam G/Michael Beyene1, Melaku Tileku Tamiru2
1Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia. Kidanemar4@gmail.com.
Tropical medicine and health
|February 5, 2025
概括
基于药房的疫苗接种计划提高了疫苗接种率和接种率,特别是在服务不足的地区. 解决监管,培训和认识差距对于它们的成功实施和广泛的公共卫生影响至关重要.
科学领域:
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
- 制药科学 制药科学
背景情况:
- 基于药房的疫苗接种计划 (PBV) 提供了一种提高疫苗接种覆盖率的策略.
- 这些计划特别适用于资源有限的环境,提高了可访问性和便利性.
- 通过增加疫苗接种率,PBV使弱势群体受益.
研究的目的:
- 分析基于药房的疫苗接种计划的潜力和挑战.
- 为优化PBV实施提供建议.
- 告知利益相关者如何最大限度地获益并最大限度地降低PBV的风险.
主要方法:
- 本评论综合了关于PBV程序的现有文献和专家意见.
- 它确定了改善监管监督,培训,协作和公众意识的关键领域.
- 为利益相关者提出了实际建议.
主要成果:
- 在增加疫苗接种覆盖率和可访问性方面,PBV计划显示出前景.
- 成功实施取决于解决监管,药剂师培训,专业间合作和公众意识的具体差距.
- 精心设计的框架和数据库对于高资源环境中可比的结果至关重要.
结论:
- 基于药房的疫苗接种是公共卫生的一个有价值的工具,特别是在资源有限的环境中.
- 解决发现的差距的战略干预可以提高PBV计划的有效性和安全性.
- 利益相关者参与和强大的基础设施是实现PBV充分潜力的关键.
相关概念视频
Vaccinations
43.9K
Overview
43.9K
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Bioequivalence: Overview
913
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
913
Routes of Drug Administration: Parenteral
1.9K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
1.9K


